{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:35Z","timestamp":1793813975041,"version":"4.6.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Outcomes for children with cancer have improved dramatically. Although the contribution of disease biology and therapy resistance to treatment failure continues to be a focus of intense research efforts, the role of medication nonadherence on the part of caregivers or patients has been relatively neglected. Efforts to further improve childhood cancer cure rates must include a focus on improving medication adherence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent studies in children with acute lymphoblastic leukemia have conclusively demonstrated that nonadherence to oral antimetabolite therapy is associated with a significant increase in relapse risk. The impact of nonadherence to other oral medications in acute lymphoblastic leukemia and in other childhood cancers remains unknown. Tools by which clinicians can accurately identify nonadherent families are currently being developed but remain suboptimal. Similarly, while current efforts to develop interventions aimed at increasing adherence rates are underway, their feasibility and effectiveness is still unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Future studies must focus on the development and widespread implementation of methods by which to identify and minimize nonadherence. Doing so will allow for further improve childhood cancer cure outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000434","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T06:19:23Z","timestamp":1477635563000},"page":"41-45","source":"Crossref","is-referenced-by-count":31,"title":["Optimizing medication adherence in children with cancer"],"prefix":"10.1097","volume":"29","author":[{"given":"Sumit","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Haematology\/Oncology, Hospital for Sick Children"},{"name":"Faculty of Medicine, Institute of Health Policy, Management, and Evaluation, and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J Clin Oncol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2011.38.9924","article-title":"Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"30","author":"Bhatia","year":"2012","journal-title":"J Clin Oncol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood-2014-01-552166","article-title":"6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"124","author":"Bhatia","year":"2014","journal-title":"Blood"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"R9-20230918","article-title":"Low socioeconomic status is associated with worse survival in children with cancer: a systematic review","volume":"9","author":"Gupta","year":"2014","journal-title":"PLoS ONE"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"S696","DOI":"10.1002\/pbc.25795","article-title":"Assessing medication adherence as a standard of care in pediatric oncology","volume":"62","author":"Pai","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20230918","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.10531","article-title":"Predicting risk for nonadherence to oral 6-mercaptopurine (6MP) in children with acute lymphoblastic leukemia (ALL) results from the Children's Oncology Group AALL03N1 study","author":"Bhatia","year":"2016","journal-title":"J Clin Oncol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaoncol.2015.0245","article-title":"Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: A Children's Onoclogy Group study","volume":"1","author":"Bhatia","year":"2015","journal-title":"JAMA Oncol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1200\/JCO.2009.22.2802","article-title":"Review of adherence-related issues in adolescents and young adults with cancer","volume":"28","author":"Butow","year":"2010","journal-title":"J Clin Oncol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejon.2013.11.007","article-title":"Adherence to outpatient oral medication regimens in adolescent hematopoietic stem cell transplant recipients","volume":"18","author":"McGrady","year":"2014","journal-title":"Eur J Oncol Nurs"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1043454211409582","article-title":"A grounded theory of the process of adherence to oral chemotherapy in Hispanic and Caucasian children and adolescents with acute lymphoblastic leukemia","volume":"28","author":"Landier","year":"2011","journal-title":"J Pediatr Oncol Nurs"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jpepsy\/jsm128","article-title":"Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions","volume":"33","author":"Kahana","year":"2008","journal-title":"J Pediatr Psychol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1026007922274","article-title":"Psychoeducational interventions with pediatric cancer patients: Part II. Effects of information and skills training on health-related outcomes","volume":"12","author":"Beale","year":"2003","journal-title":"J Child Family Studies"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1542\/peds.2007-3134","article-title":"A video game improves behavioural outcomes in adolescents and young adults with cancer: a randomized trial","volume":"122","author":"Kato","year":"2009","journal-title":"Pediatrics"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/B:JOCS.0000016267.21912.74","article-title":"Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome","volume":"11","author":"Kennard","year":"2004","journal-title":"J Clin Psychol Med Settings"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201702000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:09:21Z","timestamp":1695002961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201702000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000434","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}